EXEL FY2021 SEC EDGAR DEF 14A

Exelixis, Inc. CEO pay ratio

The CEO earned $284K in FY2021 against median worker pay of $283,758 · Chemicals & Pharmaceuticals.

State
DE
Filing date
2022-04-14
Industry
Chemicals & Pharmaceuticals
Fiscal year
FY2021

Data updated August 2026

Subscribe to Exelixis, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
27:1
Below Average (Scale: 0–1000:1)
CEO pay
$284K
Median worker
$283,758

Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.

Answer first

Exelixis, Inc. reported a 27:1 CEO-to-worker pay ratio in FY2021 - at or below the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.

Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Pay ratio
27:1
FY2021 disclosed
CEO total
$284K
Summary Compensation Table total
Median worker
$283,758
Dodd-Frank median employee

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2021

A component-level pay breakdown is not reported in Exelixis, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
27:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$284K
Companies in Industry
168
vs. Industry Median
Below

Exelixis, Inc.: MODEST · MICRO pay ratio

Exelixis, Inc. disclosed 27:1 CEO-to-worker pay and $284K CEO total in FY2021. the CEO earned 27× the median employee ($283,758) in FY2021.

Median employee $283,758 (ELITE-MED); MODEST · MICRO stamps put about 27 median-wage years per CEO year.

CEO Total Pay

$284K

FY2021 Summary Compensation, below median

Pay Ratio

27:1

Below typical

What FY2021 shows for Exelixis, Inc.

Exelixis, Inc. disclosed 27:1 CEO-to-worker pay and $284K CEO total in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Exelixis, Inc.'s $284K CEO total is at or below the $7.9M industry median CEO pay.

Exelixis, Inc. stamps MODEST · MICRO · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2021

Total Compensation
$284K
Median Employee Pay
$283,758
Pay Ratio
27:1
Filing Date
2022-04-14

Company Info

Ticker
EXEL
CIK
939767
Industry
Chemicals & Pharmaceuticals
SIC Code
2836
State
DE
SEC EDGAR DEF 14A for CIK 939767, FY2021. Informational only, not investment advice. Verify on EDGAR.

Read with Exelixis, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MICRO · ELITE-MED.

Data sourced from SEC EDGAR DEF 14A for Exelixis, Inc. (CIK 939767), FY2021. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.